XML 50 R39.htm IDEA: XBRL DOCUMENT v3.25.2
Derivatives (Tables)
6 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Primary Risks Managed by Derivatives
The following table presents the primary underlying risk exposure, gross notional amount and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:
June 30, 2025December 31, 2024
Primary Underlying Risk ExposureGross
Notional
Amount
Estimated Fair ValueGross
Notional
Amount
Estimated Fair Value
AssetsLiabilitiesAssetsLiabilities
(In millions)
Derivatives Designated as Hedging Instruments:
Fair value hedges:
Interest rate swapsInterest rate$5,108 $1,006 $651 $5,188 $1,018 $666 
Foreign currency swapsForeign currency exchange rate1,044 30 1,454 33 67 
Foreign currency forwardsForeign currency exchange rate150 — 36 150 — 41 
Subtotal6,302 1,036 695 6,792 1,051 774 
Cash flow hedges:
Interest rate swapsInterest rate4,164 14 299 4,154 — 359 
Interest rate forwardsInterest rate4,796 57 1,114 4,901 56 880 
Foreign currency swapsForeign currency exchange rate46,804 2,442 2,066 45,879 2,858 1,877 
Subtotal55,764 2,513 3,479 54,934 2,914 3,116 
Net investment in a foreign operation (“NIFO”) hedges:
Foreign currency forwardsForeign currency exchange rate1,236 44 1,553 42 — 
Currency optionsForeign currency exchange rate3,100 443 — 3,000 536 — 
Subtotal4,336 445 44 4,553 578 — 
Total qualifying hedges66,402 3,994 4,218 66,279 4,543 3,890 
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate swapsInterest rate26,669 1,454 1,304 29,238 1,414 1,263 
Interest rate floorsInterest rate5,640 60 — 6,169 38 — 
Interest rate capsInterest rate16,648 56 17,998 133 
Interest rate futuresInterest rate2,195 13 1,667 
Interest rate optionsInterest rate32,573 196 132 34,939 210 217 
Interest rate forwardsInterest rate3,221 146 109 3,128 135 77 
Synthetic GICsInterest rate53,740 — — 49,599 — — 
Foreign currency swapsForeign currency exchange rate11,593 937 326 10,708 1,192 190 
Foreign currency forwardsForeign currency exchange rate14,284 73 758 13,471 47 1,277 
Currency futuresForeign currency exchange rate315 — — 301 — 
Currency optionsForeign currency exchange rate500 34 52 — — — 
Credit default swaps — purchasedCredit2,771 63 2,791 14 67 
Credit default swaps — writtenCredit11,954 238 11,764 201 
Equity futuresEquity market1,691 20 1,840 
Equity index optionsEquity market11,717 270 320 12,743 233 253 
Equity variance swapsEquity market121 — 114 — 
Equity total return swapsEquity market1,799 — 230 1,799 41 
Longevity swaps
Longevity1,000 — — 1,000 — — 
Total non-designated or nonqualifying derivatives198,431 3,483 3,325 199,269 3,669 3,369 
Total$264,833 $7,477 $7,543 $265,548 $8,212 $7,259 
Included in the table above, the Company uses various over-the-counter (“OTC”) and exchange traded derivatives to hedge variable annuity guarantees. The table below presents the gross notional amount, estimated fair value and primary underlying risk exposure of the derivatives hedging variable annuity guarantees accounted for as MRBs:
June 30, 2025December 31, 2024
Primary Underlying Risk ExposureGross
Notional
Amount
Estimated Fair ValueGross
Notional
Amount
Estimated Fair Value
AssetsLiabilitiesAssetsLiabilities
(In millions)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate$9,148 $$712 $8,913 $11 $768 
Foreign currency exchange rate576 17 378 — 
Equity market4,035 101 330 4,294 132 113 
$13,759 $110 $1,059 $13,585 $143 $883 
The Effects of Derivatives on the Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
The following table presents the interim condensed consolidated financial statement location and amount of gain (loss) recognized on fair value, cash flow, NIFO, nonqualifying hedging relationships and embedded derivatives:
Three Months Ended June 30, 2025
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)$— $— N/A$$11 $— N/A
Hedged items— — N/A(8)(12)— N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)(18)N/A— 87 — N/A
Hedged items17 (4)N/A— (87)— N/A
Amount excluded from the assessment of hedge effectiveness— (1)N/A— — — N/A
Subtotal
(1)— N/A(6)(1)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A$(235)
Amount of gains (losses) reclassified from AOCI into income— — — — (15)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A(801)
Amount of gains (losses) reclassified from AOCI into income1,086 — — — — (1,087)
Foreign currency transaction gains (losses) on hedged items— (1,091)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — — — 
Subtotal
— — — — (2,138)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A(71)
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A(9)
Subtotal
N/A— N/AN/AN/AN/A(80)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)— N/A(272)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)— N/A(317)N/AN/AN/AN/A
Credit derivatives — purchased (1)— N/A(6)N/AN/AN/AN/A
Credit derivatives — written (1)— N/A38 N/AN/AN/AN/A
Equity derivatives (1)(28)N/A(441)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items— N/A99 N/AN/AN/AN/A
Subtotal
(28)N/A(899)N/AN/AN/AN/A
Earned income on derivatives(9)— 106 (34)— — 
Synthetic GICsN/AN/A21 N/AN/AN/AN/A
Embedded derivatives - ceded reinsurance
N/AN/A(22)N/AN/AN/AN/A
Embedded derivatives - other
N/AN/A(2)N/AN/AN/AN/A
Total
$(31)$$(796)$(4)$(35)$— $(2,218)
Three Months Ended June 30, 2024
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)$— $— N/A$(41)$(15)$— N/A
Hedged items— — N/A34 13 — N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)(2)(26)N/A— (7)— N/A
Hedged items19 N/A— — N/A
Amount excluded from the assessment of hedge effectiveness— — N/A— — — N/A
Subtotal
— (7)N/A(7)(2)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A$(264)
Amount of gains (losses) reclassified from AOCI into income(3)— — — — (2)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A104 
Amount of gains (losses) reclassified from AOCI into income(8)— — — — 
Foreign currency transaction gains (losses) on hedged items— (2)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — (1)
Subtotal
(12)— — — — (157)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A184 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A17 
Subtotal
N/A— N/AN/AN/AN/A201 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)— N/A(218)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)— N/A(564)N/AN/AN/AN/A
Credit derivatives — purchased (1)— N/AN/AN/AN/AN/A
Credit derivatives — written (1)— N/A(12)N/AN/AN/AN/A
Equity derivatives (1)(11)N/A(108)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items— N/A178 N/AN/AN/AN/A
Subtotal
(11)N/A(715)N/AN/AN/AN/A
Earned income on derivatives53 — 180 (2)(44)— — 
Synthetic GICsN/AN/A19 N/AN/AN/AN/A
Embedded derivativesN/AN/AN/AN/AN/AN/A
Total
$49 $(19)$(508)$(9)$(46)$— $44 
Six Months Ended June 30, 2025
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$(1)$— N/A$77 $53 $— N/A
Hedged items
— N/A(87)(52)— N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
(28)13  N/A — 123 — N/A
Hedged items
27 (10) N/A — (123)— N/A
Amount excluded from the assessment of hedge effectiveness
— (4) N/A — — — N/A
Subtotal
(1)(1)N/A(10)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$(122)
Amount of gains (losses) reclassified from AOCI into income
23 — — — — (32)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A(680)
Amount of gains (losses) reclassified from AOCI into income
1,446 — — — — (1,449)
Foreign currency transaction gains (losses) on hedged items
— (1,449)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — — — 
Subtotal
26 — — — — (2,283)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A(143)
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A(23)
Subtotal
N/A— N/AN/AN/AN/A(166)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A(174)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A(72)N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/A(15)N/AN/AN/AN/A
Credit derivatives — written (1)
— N/A11 N/AN/AN/AN/A
Equity derivatives (1)
(11)N/A(382)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A68 N/AN/AN/AN/A
Subtotal
(11)N/A(564)N/AN/AN/AN/A
Earned income on derivatives
86 — 216 (74)— — 
Synthetic GICsN/AN/A40 N/AN/AN/AN/A
Embedded derivatives - ceded reinsurance
N/AN/A(57)N/AN/AN/AN/A
Embedded derivatives - other
N/AN/AN/AN/AN/AN/A
Total
$100 $$(364)$(6)$(73)$— $(2,449)
Six Months Ended June 30, 2024
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$— $— N/A$(150)$(58)$— N/A
Hedged items
— — N/A137 55 — N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
(57)N/A— (31)— N/A
Hedged items
— 42 N/A— 35 — N/A
Amount excluded from the assessment of hedge effectiveness
— N/A— — — N/A
Subtotal
(11)N/A(13)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$(482)
Amount of gains (losses) reclassified from AOCI into income
13 (1)— — — — (12)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A(19)
Amount of gains (losses) reclassified from AOCI into income
(376)— — — — 373 
Foreign currency transaction gains (losses) on hedged items
— 349 — — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income
— — — — — (1)
Subtotal
16 (27)— — — — (141)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A344 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A37 
Subtotal
N/A— N/AN/AN/AN/A381 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A(571)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A(1,270)N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/AN/AN/AN/AN/A
Credit derivatives — written (1)
— N/A22 N/AN/AN/AN/A
Equity derivatives (1)
(36)N/A(450)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A341 N/AN/AN/AN/A
Subtotal
(36)N/A(1,926)N/AN/AN/AN/A
Earned income on derivatives
83 — 361 (6)(93)— — 
Synthetic GICsN/AN/A38 N/AN/AN/AN/A
Embedded derivativesN/AN/A40 N/AN/AN/AN/A
Total
$65 $(38)$(1,487)$(19)$(92)$— $240 
__________________
(1)Excludes earned income on derivatives.
Fair Value Hedges
The following table presents the balance sheet classification, carrying amount and cumulative fair value hedging adjustments for items designated and qualifying as hedged items in fair value hedges:
Balance Sheet Line ItemCarrying Amount
 of the Hedged
Assets/(Liabilities)
Cumulative Amount
of Fair Value Hedging Adjustments
Included in the Carrying Amount of Hedged
Assets/(Liabilities) (1)
June 30, 2025December 31, 2024June 30, 2025December 31, 2024
(In millions)
Fixed maturity securities AFS$239 $241 $— $— 
Mortgage loans$126 $130 $— $(1)
FPBs$(2,566)$(2,583)$282 $359 
PABs$(2,528)$(2,170)$(17)$223 
__________________
(1)Includes ($79) million and ($91) million of hedging adjustments on discontinued hedging relationships at June 30, 2025 and December 31, 2024, respectively.
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
June 30, 2025December 31, 2024
Rating Agency Designation of Referenced
Credit Obligations (1)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (3)
$$72 1.6$$72 1.9
Credit default swaps referencing indices
63 4,046 1.872 4,126 2.2
Subtotal
64 4,118 1.873 4,198 2.2
Baa
Single name credit default swaps (3)
42 4.1102 1.6
Credit default swaps referencing indices
146 7,428 5.0111 7,263 4.1
Subtotal
147 7,470 5.0112 7,365 4.1
Ba
Single name credit default swaps (3)
— 5.0— 17 1.1
Credit default swaps referencing indices
25 1.525 2.0
Subtotal
28 1.942 1.6
B
Single name credit default swaps (3)
— 19 1.0— — 0.0
Credit default swaps referencing indices
22 304 4.110 144 3.7
Subtotal
22 323 3.910 144 3.7
Caa
Credit default swaps referencing indices
(1)15 1.5(1)15 2.0
Subtotal
(1)15 1.5(1)15 2.0
Total
$233 $11,954 3.8$196 $11,764 3.4
_________________
(1)The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service, Inc. (“Moody’s”), Standard & Poor’s Global Ratings (“S&P”) and Fitch Ratings Inc. If no rating is available from a rating agency, then an internally developed rating is used.
(2)The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.
(3)Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or municipals.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
June 30, 2025December 31, 2024
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$7,351 $7,141 $8,224 $6,966 
OTC-cleared (1)
196 414 135 299 
Exchange-traded
14 21 11 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
7,561 7,576 8,370 7,272 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,281)(3,281)(3,633)(3,633)
OTC-cleared
(6)(6)(5)(5)
Exchange-traded
(3)(3)(1)(1)
Cash collateral: (3), (4)
OTC-bilateral
(1,484)(20)(2,597)— 
OTC-cleared
(169)(396)(126)(289)
Exchange-traded
— (14)— (6)
Securities collateral: (5)
OTC-bilateral
(2,544)(3,827)(1,955)(3,325)
OTC-cleared
— (11)— (4)
Exchange-traded
— (4)— — 
Net amount after application of master netting agreements and collateral
$74 $14 $53 $
__________________
(1)At June 30, 2025 and December 31, 2024, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $84 million and $158 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of $33 million and $13 million, respectively.
(2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At June 30, 2025 and December 31, 2024, the Company received excess cash collateral of $49 million and $26 million, respectively, and provided excess cash collateral of $74 million and $86 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at June 30, 2025, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At
June 30, 2025 and December 31, 2024, the Company received excess securities collateral with an estimated fair value of $385 million and $410 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At June 30, 2025 and December 31, 2024, the Company provided excess securities collateral with an estimated fair value of $1.5 billion and $1.2 billion, respectively, for its OTC-bilateral derivatives, $727 million and $835 million, respectively, for its OTC-cleared derivatives, and $224 million and $148 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
June 30, 2025December 31, 2024
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$7,351 $7,141 $8,224 $6,966 
OTC-cleared (1)
196 414 135 299 
Exchange-traded
14 21 11 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
7,561 7,576 8,370 7,272 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,281)(3,281)(3,633)(3,633)
OTC-cleared
(6)(6)(5)(5)
Exchange-traded
(3)(3)(1)(1)
Cash collateral: (3), (4)
OTC-bilateral
(1,484)(20)(2,597)— 
OTC-cleared
(169)(396)(126)(289)
Exchange-traded
— (14)— (6)
Securities collateral: (5)
OTC-bilateral
(2,544)(3,827)(1,955)(3,325)
OTC-cleared
— (11)— (4)
Exchange-traded
— (4)— — 
Net amount after application of master netting agreements and collateral
$74 $14 $53 $
__________________
(1)At June 30, 2025 and December 31, 2024, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $84 million and $158 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of $33 million and $13 million, respectively.
(2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At June 30, 2025 and December 31, 2024, the Company received excess cash collateral of $49 million and $26 million, respectively, and provided excess cash collateral of $74 million and $86 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at June 30, 2025, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At
June 30, 2025 and December 31, 2024, the Company received excess securities collateral with an estimated fair value of $385 million and $410 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At June 30, 2025 and December 31, 2024, the Company provided excess securities collateral with an estimated fair value of $1.5 billion and $1.2 billion, respectively, for its OTC-bilateral derivatives, $727 million and $835 million, respectively, for its OTC-cleared derivatives, and $224 million and $148 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of OTC-bilateral derivatives after considering effect of netting agreements
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
June 30, 2025December 31, 2024
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position (1)$3,834 $26 $3,860 $3,213 $120 $3,333 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$4,751 $47 $4,798 $3,829 $124 $3,953 
Cash$20 $— $20 $— $— $— 
__________________
(1)After taking into consideration the existence of netting agreements.
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationJune 30, 2025December 31, 2024
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld on ceded reinsurance
Other liabilities$(105)$(163)
Fixed annuities with equity indexed returns
PABs
15 172 
Total
$(90)$
Embedded Derivatives
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
June 30, 2025December 31, 2024
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position (1)$3,834 $26 $3,860 $3,213 $120 $3,333 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$4,751 $47 $4,798 $3,829 $124 $3,953 
Cash$20 $— $20 $— $— $— 
__________________
(1)After taking into consideration the existence of netting agreements.
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationJune 30, 2025December 31, 2024
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld on ceded reinsurance
Other liabilities$(105)$(163)
Fixed annuities with equity indexed returns
PABs
15 172 
Total
$(90)$